Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2526
2.570
Why?
Smoking
20
2019
1627
1.200
Why?
Bronchi
13
2018
260
1.190
Why?
Carcinoma in Situ
5
2019
49
1.090
Why?
Carcinogens
4
2012
125
0.740
Why?
Carcinoma, Squamous Cell
10
2018
683
0.740
Why?
Chemoprevention
3
2019
92
0.710
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
86
0.710
Why?
Lung
16
2020
4060
0.590
Why?
Carcinoma, Small Cell
7
2008
172
0.490
Why?
Bronchoscopy
9
2019
223
0.480
Why?
Urethane
3
2012
43
0.470
Why?
Bronchopulmonary Dysplasia
2
2019
383
0.460
Why?
Sputum
8
2019
311
0.450
Why?
Pulmonary Alveoli
4
2012
405
0.450
Why?
Iloprost
2
2012
45
0.450
Why?
Hyperplasia
7
2011
175
0.450
Why?
Precancerous Conditions
7
2020
169
0.430
Why?
Neprilysin
3
1998
47
0.410
Why?
Quinazolines
2
2012
251
0.390
Why?
Piperidines
2
2012
206
0.380
Why?
Biomarkers, Tumor
7
2015
1276
0.380
Why?
Biopsy
11
2019
1129
0.380
Why?
Antineoplastic Agents
4
2013
2129
0.370
Why?
DNA Copy Number Variations
1
2011
182
0.340
Why?
Bombesin
5
1998
11
0.340
Why?
Genetic Markers
1
2011
344
0.340
Why?
Amidohydrolases
3
1998
31
0.330
Why?
Neurosecretory Systems
4
2004
32
0.310
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
1081
0.310
Why?
Ki-67 Antigen
3
2015
112
0.310
Why?
Isotretinoin
1
2009
26
0.310
Why?
Tocopherols
1
2009
26
0.310
Why?
Vasodilator Agents
1
2011
331
0.310
Why?
ErbB Receptors
1
2012
614
0.300
Why?
Membrane Proteins
2
2008
1164
0.280
Why?
Neovascularization, Pathologic
6
2015
301
0.280
Why?
Mass Screening
3
2008
1287
0.280
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
1040
0.270
Why?
Respiratory Mucosa
2
2008
321
0.250
Why?
Adenocarcinoma
6
2012
940
0.240
Why?
Hypoxia
1
2012
1112
0.230
Why?
Chromosomes, Human, Pair 3
4
2000
50
0.220
Why?
Carcinoma, Bronchogenic
2
2002
20
0.210
Why?
Chromosome Aberrations
4
2013
156
0.210
Why?
Middle Aged
28
2019
33479
0.200
Why?
Tomography, Spiral Computed
1
2002
32
0.200
Why?
Aged
25
2019
23961
0.200
Why?
Humans
53
2020
137585
0.180
Why?
Sensitivity and Specificity
10
2010
1946
0.180
Why?
Smokers
2
2019
145
0.180
Why?
Female
33
2019
73304
0.180
Why?
Placebos
2
2019
199
0.180
Why?
Lung Diseases
5
2015
767
0.180
Why?
Small Cell Lung Carcinoma
2
2012
96
0.180
Why?
Double-Blind Method
2
2019
1993
0.170
Why?
Tomography, X-Ray Computed
2
2020
2691
0.160
Why?
Male
30
2019
67762
0.160
Why?
Neuropeptides
4
1998
73
0.160
Why?
Tumor Cells, Cultured
6
1998
955
0.160
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
110
0.160
Why?
Remission Induction
1
2019
288
0.150
Why?
In Situ Hybridization, Fluorescence
6
2010
317
0.140
Why?
Peptides
3
1996
985
0.140
Why?
Blotting, Western
4
2012
1226
0.140
Why?
Genes, p53
1
1997
72
0.140
Why?
Lung Diseases, Obstructive
1
1997
50
0.140
Why?
Antibodies, Monoclonal
3
2010
1430
0.130
Why?
Immunohistochemistry
8
2015
1738
0.130
Why?
Point Mutation
1
1997
235
0.130
Why?
Radiation Injuries, Experimental
1
1996
22
0.120
Why?
Proteomics
2
2015
1111
0.120
Why?
Bradykinin
1
1996
46
0.120
Why?
Endopeptidases
1
1996
90
0.120
Why?
Chromosomal Instability
2
2013
19
0.120
Why?
Hyperoxia
1
1996
90
0.120
Why?
Smoking Cessation
1
2019
442
0.120
Why?
Multiple Pulmonary Nodules
1
2015
23
0.120
Why?
Mice
10
2012
17787
0.120
Why?
Animals
13
2013
36940
0.110
Why?
Gene Expression
3
1998
1502
0.110
Why?
Methylcholanthrene
2
2012
22
0.110
Why?
Antigens
1
1996
357
0.110
Why?
Butylated Hydroxytoluene
2
2012
38
0.110
Why?
Mice, Transgenic
5
2009
2167
0.110
Why?
Risk Factors
5
2019
10388
0.110
Why?
Microarray Analysis
1
2013
117
0.110
Why?
Stem Cells
1
2018
594
0.100
Why?
Algorithms
3
2020
1704
0.100
Why?
Aged, 80 and over
8
2015
7635
0.100
Why?
Mutation
4
2000
3958
0.100
Why?
Epithelium
4
2018
313
0.100
Why?
Intramolecular Oxidoreductases
2
2004
68
0.100
Why?
Carcinoma, Large Cell
1
2012
16
0.100
Why?
Risk
5
2012
912
0.100
Why?
Biological Products
1
1996
216
0.100
Why?
Cytochrome P-450 Enzyme System
2
2004
155
0.100
Why?
Epithelial Cells
3
2007
1096
0.100
Why?
Receptors, Bombesin
1
2012
2
0.100
Why?
Bronchoalveolar Lavage Fluid
3
2002
652
0.090
Why?
Immunoenzyme Techniques
1
2012
219
0.090
Why?
Volatile Organic Compounds
1
2012
61
0.090
Why?
Cell Division
4
2000
794
0.090
Why?
Case-Control Studies
8
2012
3556
0.090
Why?
Sleep Apnea Syndromes
1
2012
88
0.090
Why?
Dose-Response Relationship, Drug
2
2010
2057
0.090
Why?
Proto-Oncogene Proteins c-myc
1
2012
139
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
55
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.090
Why?
Veterans
1
2002
1476
0.090
Why?
Epithelial-Mesenchymal Transition
1
2012
209
0.080
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
243
0.080
Why?
Antioxidants
2
2012
584
0.080
Why?
Plants, Toxic
1
1989
24
0.080
Why?
Cell Line
5
2013
2847
0.080
Why?
Proteins
1
1996
1009
0.080
Why?
Somatomedins
1
2009
27
0.080
Why?
Calcium
1
1996
1199
0.080
Why?
Genome-Wide Association Study
2
2013
1431
0.080
Why?
Predictive Value of Tests
4
2009
2031
0.080
Why?
Disease Progression
5
2018
2757
0.080
Why?
Cell Proliferation
2
2018
2475
0.080
Why?
Bronchial Neoplasms
1
2009
15
0.080
Why?
Intracellular Signaling Peptides and Proteins
2
2011
455
0.080
Why?
Chromosome Deletion
1
1989
115
0.080
Why?
Adult
16
2018
37929
0.070
Why?
Neoplasms, Glandular and Epithelial
1
2009
49
0.070
Why?
Airway Obstruction
3
2009
162
0.070
Why?
Respiratory System
1
1989
157
0.070
Why?
GPI-Linked Proteins
1
2008
73
0.070
Why?
Neoplasm Invasiveness
4
2015
510
0.070
Why?
Fluorescence
3
2009
160
0.070
Why?
Alkaline Phosphatase
1
2008
148
0.070
Why?
Polymorphism, Genetic
1
2011
660
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Isoenzymes
1
2008
304
0.070
Why?
Molecular Targeted Therapy
1
2010
411
0.070
Why?
Cell Transformation, Neoplastic
1
2009
327
0.070
Why?
Inflammation
1
2018
2837
0.070
Why?
Molecular Sequence Data
5
1998
2900
0.070
Why?
Pulmonary Surfactants
2
1999
106
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
267
0.070
Why?
Fibroblasts
3
1998
996
0.070
Why?
Exons
2
1998
355
0.060
Why?
MicroRNAs
1
2012
692
0.060
Why?
Follow-Up Studies
2
2015
5131
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2189
0.060
Why?
Early Detection of Cancer
1
2010
447
0.060
Why?
ROC Curve
3
2015
554
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
852
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
430
0.060
Why?
Recombinant Proteins
3
1998
1353
0.060
Why?
Biomarkers
3
2010
4149
0.060
Why?
Polymerase Chain Reaction
3
1998
1062
0.060
Why?
RNA, Messenger
3
1998
2833
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
24
0.060
Why?
Acromegaly
1
2004
14
0.060
Why?
Protein Kinase Inhibitors
1
2010
916
0.050
Why?
Cytokines
1
2012
2085
0.050
Why?
Adrenocorticotropic Hormone
1
2004
143
0.050
Why?
Rats
4
2004
5647
0.050
Why?
Smoke
1
2004
141
0.050
Why?
Base Sequence
3
1998
2181
0.050
Why?
Solitary Pulmonary Nodule
1
2002
22
0.050
Why?
Neoplasm Recurrence, Local
1
2009
1079
0.050
Why?
Metaplasia
2
2018
60
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
545
0.050
Why?
Cross-Sectional Studies
2
2018
5472
0.050
Why?
Sex Factors
1
2007
2071
0.050
Why?
Hospitals, Veterans
1
2002
252
0.040
Why?
Pulmonary Fibrosis
2
1998
402
0.040
Why?
Radiation Dosage
1
2002
179
0.040
Why?
Reproducibility of Results
1
2008
3284
0.040
Why?
Gene Expression Regulation
1
1989
2607
0.040
Why?
Amino Acid Sequence
3
1994
2139
0.040
Why?
Cohort Studies
4
2015
5742
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Autocrine Communication
1
1998
41
0.040
Why?
Desmoglein 3
1
2018
15
0.040
Why?
gamma Catenin
1
2018
13
0.040
Why?
Light
1
2001
381
0.040
Why?
Loss of Heterozygosity
2
2013
51
0.040
Why?
Feasibility Studies
1
2002
956
0.040
Why?
DNA Primers
2
1998
515
0.040
Why?
Signal Transduction
3
1998
5079
0.040
Why?
Up-Regulation
2
2005
843
0.040
Why?
Bronchial Diseases
1
2018
37
0.040
Why?
Paracrine Communication
1
1998
65
0.040
Why?
Neoplasm Transplantation
1
1998
257
0.040
Why?
Time
1
2018
83
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
39
0.040
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
13
0.040
Why?
Polymorphism, Single-Stranded Conformational
1
1997
26
0.040
Why?
Cell Cycle Checkpoints
1
2018
98
0.040
Why?
Genes, Tumor Suppressor
1
1998
86
0.040
Why?
Gene Expression Profiling
1
2005
1774
0.040
Why?
Alveolitis, Extrinsic Allergic
1
1998
97
0.040
Why?
Polymorphism, Restriction Fragment Length
1
1997
68
0.030
Why?
Likelihood Functions
1
1998
144
0.030
Why?
DNA, Complementary
1
1998
272
0.030
Why?
Gene Expression Regulation, Enzymologic
1
1998
283
0.030
Why?
Codon
1
1997
89
0.030
Why?
Neoplasm Staging
2
2012
1389
0.030
Why?
Introns
1
1998
258
0.030
Why?
United States
2
2011
14841
0.030
Why?
Mice, Nude
1
1998
698
0.030
Why?
Membrane Glycoproteins
1
1999
500
0.030
Why?
Treatment Outcome
1
2011
10811
0.030
Why?
Immunoassay
2
1998
115
0.030
Why?
Incidence
3
2010
2804
0.030
Why?
Enzyme Activation
1
1998
810
0.030
Why?
RNA, Neoplasm
1
1996
82
0.030
Why?
Glycopeptides
1
1996
43
0.030
Why?
Image Processing, Computer-Assisted
1
2020
752
0.030
Why?
Mesothelioma
1
1996
44
0.030
Why?
Antigens, CD
2
1998
521
0.030
Why?
Sequence Analysis, DNA
1
1998
812
0.030
Why?
Machine Learning
1
2020
493
0.030
Why?
Proto-Oncogene Proteins
1
2018
648
0.030
Why?
Databases, Factual
1
2020
1357
0.030
Why?
Cell Cycle Proteins
1
2018
617
0.030
Why?
Receptors, Peptide
1
1994
17
0.030
Why?
Myelin Sheath
1
1996
167
0.030
Why?
Rh-Hr Blood-Group System
1
1994
12
0.030
Why?
Erythrocyte Membrane
1
1994
55
0.030
Why?
Blotting, Southern
1
1993
73
0.030
Why?
Blotting, Northern
1
1993
201
0.030
Why?
Prospective Studies
3
2012
7604
0.030
Why?
Neoplasm Metastasis
1
1996
658
0.030
Why?
DNA, Neoplasm
1
1993
164
0.020
Why?
Solid Phase Microextraction
1
2012
9
0.020
Why?
Cells, Cultured
2
2007
4193
0.020
Why?
Endoscopy
1
2015
318
0.020
Why?
Dinoprostone
2
2004
191
0.020
Why?
Fluorescent Antibody Technique
1
1993
390
0.020
Why?
Cloning, Molecular
1
1993
534
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
132
0.020
Why?
Breath Tests
1
2012
87
0.020
Why?
Enzyme Inhibitors
1
1996
840
0.020
Why?
Colorado
1
2002
4565
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2018
1396
0.020
Why?
Liver Neoplasms
1
1998
786
0.020
Why?
Iceland
1
2011
11
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
13
0.020
Why?
Spain
1
2011
41
0.020
Why?
Netherlands
1
2011
88
0.020
Why?
Respiratory Tract Diseases
1
1992
184
0.020
Why?
Cattle
1
1993
984
0.020
Why?
Administration, Oral
1
2012
816
0.020
Why?
Rats, Sprague-Dawley
1
1996
2486
0.020
Why?
Meta-Analysis as Topic
1
2011
186
0.020
Why?
Severity of Illness Index
1
2018
2828
0.020
Why?
Receptor, IGF Type 1
1
2009
65
0.020
Why?
Carrier Proteins
1
1994
771
0.020
Why?
Flow Cytometry
1
1993
1178
0.020
Why?
Prognosis
2
2012
4030
0.020
Why?
Area Under Curve
1
2010
314
0.020
Why?
International Agencies
1
2009
35
0.020
Why?
Cystic Fibrosis
1
1998
1114
0.020
Why?
Erythrocytes
1
1994
700
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
597
0.020
Why?
Mass Spectrometry
1
2010
739
0.020
Why?
Pilot Projects
1
2012
1710
0.020
Why?
Genome, Human
1
2009
425
0.020
Why?
Models, Statistical
1
2010
669
0.020
Why?
Amino Acids
1
1989
497
0.020
Why?
Genotype
1
2011
1916
0.020
Why?
Disease Models, Animal
1
1996
4295
0.010
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
108
0.010
Why?
Genomics
1
2009
795
0.010
Why?
Epoprostenol
1
2004
136
0.010
Why?
Bronchiolitis
1
2004
80
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
976
0.010
Why?
Autoantibodies
1
2010
1496
0.010
Why?
Fruit
1
2003
140
0.010
Why?
Vegetables
1
2003
157
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
767
0.010
Why?
Respiratory Function Tests
1
2004
600
0.010
Why?
Pituitary Neoplasms
1
2004
190
0.010
Why?
Genetic Predisposition to Disease
1
2011
2426
0.010
Why?
Adenoma
1
2004
230
0.010
Why?
Regression Analysis
1
2003
1024
0.010
Why?
Single-Blind Method
1
2001
282
0.010
Why?
Weight Gain
1
2004
519
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
52
0.010
Why?
Carcinoma
1
2001
240
0.010
Why?
Bronchoscopes
1
1998
4
0.010
Why?
RNA
1
2005
921
0.010
Why?
Endoglin
1
1998
19
0.010
Why?
Random Allocation
1
1998
353
0.010
Why?
Genetic Linkage
1
1998
297
0.010
Why?
Retrospective Studies
1
2015
15657
0.010
Why?
Reference Values
1
1998
816
0.010
Why?
Comorbidity
1
2001
1622
0.010
Why?
Linear Models
1
1998
849
0.010
Why?
Longitudinal Studies
1
2003
2844
0.010
Why?
Tumor Suppressor Protein p53
1
2000
528
0.010
Why?
Analysis of Variance
1
1998
1316
0.010
Why?
Receptors, Cell Surface
1
1998
385
0.010
Why?
Diet
1
2003
1278
0.010
Why?
Alleles
1
1998
891
0.010
Why?
Young Adult
1
2011
13209
0.010
Why?
Risk Assessment
1
2004
3457
0.010
Why?
Chromatography, Affinity
1
1994
88
0.010
Why?
Infant, Premature
1
1998
574
0.010
Why?
CD47 Antigen
1
1994
38
0.010
Why?
Endothelium, Vascular
1
2000
927
0.010
Why?
Genes
1
1994
230
0.010
Why?
Moths
1
1994
45
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
345
0.010
Why?
Cytoplasm
1
1994
274
0.010
Why?
Carcinoid Tumor
1
1992
26
0.010
Why?
Chromosome Mapping
1
1994
523
0.010
Why?
Lymphocytes
1
1994
397
0.010
Why?
Transfection
1
1994
945
0.010
Why?
Adolescent
1
2011
21513
0.010
Why?
Mice, Inbred BALB C
1
1994
1272
0.010
Why?
Binding Sites
1
1994
1303
0.010
Why?
Dyspnea
1
1992
254
0.010
Why?
Fibrosis
1
1992
552
0.010
Why?
Phenotype
1
1998
3196
0.000
Why?
Aging
1
1998
1864
0.000
Why?
Infant, Newborn
1
1998
6079
0.000
Why?
Infant
1
1998
9465
0.000
Why?
Child, Preschool
1
1998
11074
0.000
Why?
Child
1
1998
21935
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)